{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:43:23Z","timestamp":1787161403546,"version":"build-2736575974"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Tianjin Key Medical Discipline Construction","award":["TJYXZDXK-3-006B"],"award-info":[{"award-number":["TJYXZDXK-3-006B"]}]},{"name":"Tianjin Key Medical Discipline Construction","award":["TJWJ2022XK013"],"award-info":[{"award-number":["TJWJ2022XK013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension and diabetes mellitus are both known risk factors for atrial fibrillation (AF). Whether coexisting hypertension exacerbates AF risk among individuals with diabetes remains unclear. This study aims to investigate the association between hypertension and incident AF in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied participants in the prospective Kailuan Study, including 18,084 adults diagnosed with diabetes between 2006 and 2011 and free of AF at baseline. Hypertension was defined by a previous diagnosis, use of antihypertensive medications, or systolic\/diastolic blood pressure \u2265140\/90 mm\u00a0Hg. Incident AF was identified via biennial electrocardiograms and hospital records. Cox proportional hazards models adjusted for demographic, lifestyle, metabolic, and clinical covariates were used to estimate hazard ratios (HRs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a median follow-up of 14.8 years (interquartile range 12.7-16.8), 275 participants with diabetes developed AF, and 5,265 died from any cause. Hypertension was associated with a higher risk of AF (adjusted HR, 1.48; 95% confidence interval [CI], 1.05-2.07) compared to those without hypertension. Compared to participants with normal blood pressure, the adjusted HRs for AF were 1.54 (95% CI, 1.11-2.13) for grade 1 hypertension and 1.61 (95% CI, 1.06-2.44) for grade 2 hypertension. Among those with hypertension, target organ damage\u2014particularly prior myocardial infarction or ischemic stroke\u2014further elevated AF risk (HR, 2.66; 95% CI, 1.26-5.60).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hypertension independently increases AF risk in individuals with diabetes, especially with higher blood pressure levels and target organ damage. Early hypertension control is crucial for the prevention of AF in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajh\/hpag011","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:42:39Z","timestamp":1770900159000},"page":"892-900","source":"Crossref","is-referenced-by-count":3,"title":["Hypertension and new-onset atrial fibrillation in participants with diabetes mellitus: a report from the population-based Kailuan study"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0885-3779","authenticated-orcid":false,"given":"Hongmin","family":"Liu","sequence":"first","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University , Tianjin,","place":["China"]},{"name":"Department of Cardiology, Kailuan General Hospital , Tangshan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonglian","family":"Lyu","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University , Tianjin,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kailuan General Hospital , Tangshan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kailuan General Hospital , Tangshan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kailuan General Hospital , Tangshan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University , Tianjin,","place":["China"]},{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital , Liverpool,","place":["United Kingdom"]},{"name":"Department of Clinical Medicine, Aalborg University , Aalborg,","place":["Denmark"]},{"name":"Department of Cardiology, Lipidology and Internal Medicine, Medical University of Bialystok , Bialystok,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kailuan General Hospital , Tangshan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-0738","authenticated-orcid":false,"given":"Tong","family":"Liu","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University , Tianjin,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"2026061604105730100_hpag011-B1","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"Bmj."},{"key":"2026061604105730100_hpag011-B2","doi-asserted-by":"crossref","first-page":"100786","DOI":"10.1016\/j.lanepe.2023.100786","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg Health Eur."},{"key":"2026061604105730100_hpag011-B3","first-page":"100439","article-title":"Prevalence and risk of atrial fibrillation in China: a national cross-sectional epidemiological study","volume":"23","author":"Shi","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"2026061604105730100_hpag011-B4","first-page":"491","article-title":"An epidemiological survey of atrial fibrillation in China","volume":"43","author":"Zhou","year":"2004","journal-title":"Zhonghua Nei Ke Za Zhi."},{"key":"2026061604105730100_hpag011-B5","doi-asserted-by":"crossref","first-page":"e70086","DOI":"10.1111\/eci.70086","article-title":"Clinical associations and prognosis in Asian and European patients with symptom-controlled atrial fibrillation: insights from two prospective registries in Europe and Asia","volume":"55","author":"Teo","year":"2025","journal-title":"Eur J Clin Invest."},{"key":"2026061604105730100_hpag011-B6","doi-asserted-by":"crossref","first-page":"100784","DOI":"10.1016\/j.lanepe.2023.100784","article-title":"Atrial fibrillation: comorbidities, lifestyle, and patient factors","volume":"37","author":"Shantsila","year":"2024","journal-title":"Lancet Reg Health Eur."},{"key":"2026061604105730100_hpag011-B7","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus: JACC review topic of the week","volume":"74","author":"Wang","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"2026061604105730100_hpag011-B8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/ajh\/hpx013","article-title":"Hypertension and atrial fibrillation: an intimate association of epidemiology, pathophysiology, and outcomes","volume":"30","author":"Dzeshka","year":"2017","journal-title":"Am J Hypertens."},{"key":"2026061604105730100_hpag011-B9","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1161\/HYPERTENSIONAHA.119.13672","article-title":"Impact of the duration and degree of hypertension and body weight on new-onset atrial fibrillation: a nationwide population-based study","volume":"74","author":"Kim","year":"2019","journal-title":"Hypertension."},{"key":"2026061604105730100_hpag011-B10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/hm.HM-D-23-00028","article-title":"A narrative review on prediabetes or diabetes and atrial fibrillation: from molecular mechanisms to clinical practice","volume":"7","author":"Han","year":"2023","journal-title":"Heart Mind"},{"key":"2026061604105730100_hpag011-B11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/hm.HM-D-23-00040","article-title":"Arterial hypertension, heart failure, angina pectoris, myocardial infarction, and atrial fibrillation after COVID-19: a narrative review","volume":"8","author":"Brito","year":"2024","journal-title":"Heart Mind"},{"key":"2026061604105730100_hpag011-B12","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation."},{"key":"2026061604105730100_hpag011-B13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-025-02590-2","article-title":"Proteinuria and the risk of incident atrial fibrillation according to glycemic stages: a nationwide population-based cohort study","volume":"24","author":"Yeo","year":"2025","journal-title":"Cardiovasc Diabetol."},{"key":"2026061604105730100_hpag011-B14","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2026061604105730100_hpag011-B15","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"Jama."},{"key":"2026061604105730100_hpag011-B16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12916-022-02413-1","article-title":"Elevated levels of body mass index and waist circumference, but not high variability, are associated with an increased risk of atrial fibrillation","volume":"20","author":"Zhao","year":"2022","journal-title":"BMC Med."},{"key":"2026061604105730100_hpag011-B17","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.hrthm.2014.04.003","article-title":"Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis","volume":"11","author":"Tamariz","year":"2014","journal-title":"Heart Rhythm."},{"key":"2026061604105730100_hpag011-B18","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/eurheartj\/ehv486","article-title":"The role of obesity in atrial fibrillation","volume":"37","author":"Nalliah","year":"2016","journal-title":"Eur Heart J."},{"key":"2026061604105730100_hpag011-B19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026061604105730100_hpag011-B20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/a-2325-5923","article-title":"2024 Chinese Expert Consensus Guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary","volume":"124","author":"Wang","year":"2024","journal-title":"Thromb Haemost."},{"key":"2026061604105730100_hpag011-B21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1055\/s-0043-1769612","article-title":"Mobile health-Technology-Integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial","volume":"123","author":"Romiti","year":"2023","journal-title":"Thromb Haemost."},{"key":"2026061604105730100_hpag011-B22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0043-1772773","article-title":"Non-vitamin K antagonist oral anticoagulant, warfarin, and ABC pathway adherence on hierarchical outcomes: win ratio analysis of the COOL-AF registry","volume":"124","author":"Treewaree","year":"2024","journal-title":"Thromb Haemost."},{"key":"2026061604105730100_hpag011-B23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12933-021-01215-8","article-title":"Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study","volume":"20","author":"Ahn","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"2026061604105730100_hpag011-B24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.119.13708","article-title":"Blood pressure variability and incidence of new-onset atrial fibrillation: a nationwide population-based study","volume":"75","author":"Lee","year":"2020","journal-title":"Hypertension."},{"key":"2026061604105730100_hpag011-B25","doi-asserted-by":"crossref","first-page":"e000102","DOI":"10.1161\/JAHA.112.000102","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"2026061604105730100_hpag011-B26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jdiacomp.2018.02.004","article-title":"Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies","volume":"32","author":"Aune","year":"2018","journal-title":"J Diabetes Complications."},{"key":"2026061604105730100_hpag011-B27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1462-8902.2004.00358.x","article-title":"Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community","volume":"6","author":"Ostgren","year":"2004","journal-title":"Diabetes Obes Metab."},{"key":"2026061604105730100_hpag011-B28","doi-asserted-by":"crossref","first-page":"e13633","DOI":"10.1111\/eci.13633","article-title":"Predictive model for atrial fibrillation in hypertensive diabetic patients","volume":"51","author":"Abellana","year":"2021","journal-title":"Eur J Clin Invest."},{"key":"2026061604105730100_hpag011-B29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12933-023-01736-4","article-title":"Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study","volume":"22","author":"Choi","year":"2023","journal-title":"Cardiovasc Diabetol."},{"key":"2026061604105730100_hpag011-B30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jacep.2019.05.018","article-title":"Association between pre-ablation glycemic control and outcomes among patients with diabetes undergoing atrial fibrillation ablation","volume":"5","author":"Donnellan","year":"2019","journal-title":"JACC Clin Electrophysiol."},{"key":"2026061604105730100_hpag011-B31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation."},{"key":"2026061604105730100_hpag011-B32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41371-019-0279-7","article-title":"Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management","volume":"33","author":"Gumprecht","year":"2019","journal-title":"J Hum Hypertens."},{"key":"2026061604105730100_hpag011-B33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167517","article-title":"Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation","volume":"133","author":"Song","year":"2023","journal-title":"J Clin Invest."},{"key":"2026061604105730100_hpag011-B34","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/cvr\/cvaa258","article-title":"Pathophysiology of atrial fibrillation and chronic kidney disease","volume":"117","author":"Ding","year":"2021","journal-title":"Cardiovasc Res."},{"key":"2026061604105730100_hpag011-B35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/FJC.0000000000000253","article-title":"Calcium handling abnormalities as a target for atrial fibrillation therapeutics: how close to clinical implementation?","volume":"66","author":"Heijman","year":"2015","journal-title":"J Cardiovasc Pharmacol."},{"key":"2026061604105730100_hpag011-B36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000441-200304000-00010","article-title":"Valvular and perivalvular abnormalities in end-stage renal disease","volume":"325","author":"Umana","year":"2003","journal-title":"Am J Med Sci."},{"key":"2026061604105730100_hpag011-B37","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11100597","article-title":"Uremic toxins and atrial fibrillation: mechanisms and therapeutic implications","volume":"11.","author":"Yamagami","year":"2019","journal-title":"Toxins (Basel)"},{"key":"2026061604105730100_hpag011-B38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/joa3.12555","article-title":"Revisiting the dynamic risk profile of cardiovascular\/non-cardiovascular multimorbidity in incident atrial fibrillation patients and five cardiovascular\/non-cardiovascular outcomes: a machine-learning approach","volume":"37","author":"Lip","year":"2021","journal-title":"J Arrhythm."},{"key":"2026061604105730100_hpag011-B39","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/j.hrthm.2025.02.013","article-title":"Racial differences and similarities in atrial fibrillation epidemiology and risk factors in UK Biobank and Korean NHIS-HEALS cohort studies","volume":"22","author":"Kim","year":"2025","journal-title":"Heart Rhythm."}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpag011\/66919874\/hpag011.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/39\/7\/892\/66919874\/hpag011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/39\/7\/892\/66919874\/hpag011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:11:08Z","timestamp":1781597468000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/39\/7\/892\/8487159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,15]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpag011","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,2,15]]}}}